Related content

Limitations of S-Warfarin Truncated Area Under the Concentration-Time Curve to Predict Cytochrome P450 2c9 Activity

By  

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-06 ,pp. : 94-101

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib

By Brenner S.S.   Herrlinger C.   Dilger K.   Murdter T.E.   Hofmann U.   Marx C.   Klotz U.  

Clinical Pharmacokinetics, Vol. 42, Iss. 3, 2003-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Genotype–phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region

By Varshney Ekta   Saha Nilanjan   Tandon Monika   Shrivastava Vikesh   Ali Shakir  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

Reduced cytochrome P450 (CYP) 2D6 activity may contribute to an interaction between tramadol and warfarin

By  

Reactions Weekly, Vol. 1, Iss. 1017, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P ₄₅₀ 2D6 gene

By Hedenmalm Karin   Lindh Jonatan   Säwe Juliette   Rane Anders  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 369-372

Springer Publishing Company

Access to resources Recommend Favorite